Clinical trials
Completed Glucose Metabolism Disorders trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
85 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 3 |
| 2004 | 2 |
| 2006 | 7 |
| 2007 | 6 |
| 2008 | 5 |
| 2009 | 3 |
| 2010 | 7 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 5 |
| 2017 | 6 |
| 2018 | 8 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 85 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 19 |
| AstraZeneca | 5 |
| Pfizer | 5 |
| Eli Lilly and Company | 4 |
| Ultragenyx Pharmaceutical Inc | 4 |
| Jaeb Center for Health Research | 3 |
| Washington University School of Medicine | 3 |
| Albert Einstein College of Medicine | 2 |
| Old Dominion University | 2 |
| The University of Texas Health Science Center at San Antonio | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glucose Metabolism Disorders | 85 |
| Diabetes Mellitus | 52 |
| Diabetes Mellitus, Type 2 | 41 |
| Metabolic Diseases | 30 |
| Endocrine System Diseases | 27 |
| Dyslipidemias | 17 |
| Diabetes Mellitus, Lipoatrophic | 9 |
| Insulin Resistance | 8 |
| Autoimmune Diseases | 6 |
| Hyperglycemia | 5 |
Trials
Showing 1 to 25 of 85. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.